By KIM BELLARD Until a couple of days ago I hadn’t heard of the phrase “meat computer.” Apparently this has been around for some time, and, as Lora Kelley discusses in The New York Times, the tech elites are increasingly using it, either as a way to humanize AI or as a way to disparage…
As online pharmacies have grown in prominence, the German government aim to pass legislation to increase the profits of brick-and-mortar pharmacies in order to keep more physical locations available to Germans. Did it move sales from online to brick-and-mortar pharmacies? Is the law likely to keep brick-and-mortar pharmacies in business? These are the questions asked…
The mandatory model will hold hospitals financially accountable for joint replacement episodes from the day of surgery through 90 days post-discharge.
Through a new partnership, Teladoc Health’s virtual services are now available on Walmart’s Better Care Services platform. The post Walmart, Teladoc Team Up to Expand Access to Virtual Care appeared first on MedCity News.
CMS finalized a new rule aimed at streamlining the No Surprises Act’s overwhelmed arbitration system. Provider groups largely welcomed the reforms — though some industry leaders said additional changes are still needed to address alleged misuse and improve transparency. The post CMS Finalizes Rule to Simplify Payer-Provider Disputes Under No Surprises Act appeared first on…
The healthcare sector is prioritizing cybersecurity in device procurement, but challenges persist with legacy devices, network vulnerabilities and AI threats. To safeguard patient care, organizations must implement layered security controls, foster trust with vendors, and develop frameworks specifically targeting AI vulnerabilities, alongside ongoing device security enhancements.
AbbVie drug Decnupaz received FDA approval for treating blastic plasmacytoid dendritic cell neoplasm, or BPDCN. This antibody drug conjugate came from AbbVie’s 2023 ImmunoGen acquisition. The post AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood Cancer appeared first on MedCity News.
This brief analyzes out-of-pocket limits in Medicare Advantage plans in 2026, variation by plan type, the distribution of enrollees facing different out-of-pocket limits, and trends over time.
By JAKE SEGAL and KAREN LARSEN Call 988 in California and someone picks up. In parts of the state, a mobile crisis team might arrive at your door instead of police. Through Proposition 1, the state is putting billions into treatment beds, supportive housing, and youth services. On paper, California is in the middle of…
[Sponsored] In this episode, we’re joined by Janna Manjelievskaia, director of health economics and outcomes research at Veradigm. We discuss Veradigm’s recent Women’s Health Insights Report, which highlights the complicated history around Hormone Replacement Therapy (HRT), a medication used to treat menopause. The post MedCity FemFwd: The Complicated History Behind Hormone Replacement Therapy appeared first…